EKSO BIONICS HOLDINGS, INC.
For the period ended Dec 31, 2025. Filed Feb 23, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 23, 2026
CHRN$11.62+8.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 9B. Other Information
On* February 20, 2026,*stockholders holding a majority of the voting power of the Company, acting via written consent, approved the following in connection with the Business Combination:
| • | the Contribution Agreement and the Investor Rights Agreement, and the transactions contemplated thereby; |
|---|---|
| • | the Exchanged Shares Issuance, the issuance of the PIPE Securities and any other issuances of preferred stock, common stock and securities convertible into or exercisable for common stock pursuant to subscription, purchase or similar agreements that we may enter into prior to closing of the Business Combination, including, but not limited to, for purposes of complying with Nasdaq Listing Rule 5635; |
| • | the Second Restated Articles; and |
| • | ChronoScale’s 2026 Omnibus Equity Incentive. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.